Abstract:Background Heterogeneity of endothelial cells (ECs) is a hallmark of the vascular system which may impact the development and management of vascular disorders. Despite the tremendous progress in differentiation of human embryonic stem cells (hESCs) towards endothelial lineage, differentiation into arterial and venous endothelial phenotypes remains elusive. Additionally, current differentiation strategies are hampered by inefficiency, lack of reproducibility, and use of animal-derived products. Methods To direct the differentiation of hESCs to endothelial subtypes, H1- and H9-hESCs were seeded on human plasma fibronectin and differentiated under chemically defined conditions by sequential modulation of glycogen synthase kinase-3 (GSK-3), basic fibroblast growth factor (bFGF), bone morphogenetic protein 4 (BMP4) and vascular endothelial growth factor (VEGF) signaling pathways for 5 days. Following the initial differentiation, the endothelial progenitor cells (CD34 + CD31 + cells) were sorted and terminally differentiated under serum-free conditions to arterial and venous ECs. The transcriptome and secretome profiles of the two distinct populations of hESC-derived arterial and venous ECs were characterized. Furthermore, the safety and functionality of these cells upon in vivo transplantation were characterized. Results Sequential modulation of hESCs with GSK-3 inhibitor, bFGF, BMP4 and VEGF resulted in stages reminiscent of primitive streak, early mesoderm/lateral plate mesoderm, and endothelial progenitors under feeder- and serum-free conditions. Furthermore, these endothelial progenitors demonstrated differentiation potential to almost pure populations of arterial and venous endothelial phenotypes under serum-free conditions. Specifically, the endothelial progenitors differentiated to venous ECs in the absence of VEGF, and to arterial phenotype under low concentrations of VEGF. Additionally, these hESC-derived arterial and venous ECs showed distinct molecular and functional profiles in vitro. Furthermore, these hESC-derived arterial and venous ECs were nontumorigenic and were functional in terms of forming perfused microvascular channels upon subcutaneous implantation in the mouse. Conclusions We report a simple, rapid, and efficient protocol for directed differentiation of hESCs into endothelial progenitor cells capable of differentiation to arterial and venous ECs under feeder-free and serum-free conditions. This could offer a human platform to study arterial–venous specification for various applications related to drug discovery, disease modeling and regenerative medicine in the future.

Mesoderm is committed to hemato-endothelial and cardiac lineages in human embryoid bodies by sequential exposure to cytokines.

Differentiation of Human Embryonic Stem Cells Toward the Chondrogenic Lineage.

Short-term BMP-4 Treatment Initiates Mesoderm Induction in Human Embryonic Stem Cells

Efficient Derivation of Lateral Plate and Paraxial Mesoderm Subtypes from Human Embryonic Stem Cells Through GSKi-Mediated Differentiation

Derivation of multipotent nestin + /CD271 − /STRO-1 − mesenchymal-like precursors from human embryonic stem cells in chemically defined conditions

Efficient Differentiation of Human Embryonic Stem Cells to Arterial and Venous Endothelial Cells under Feeder- and Serum-Free Conditions

[Spontaneous Differentiation of Human Embryonic Stem Cells into Hematopoietic Cells].

In vitro hematopoietic differentiation of human embryonic stem cells induced by co-culture with human bone marrow stromal cells and low dose cytokines.

Control Differentiation of Embryonic Stem Cell to Specific Lineages

Human ESC-derived Hemogenic Endothelial Cells Undergo Distinct Waves of Endothelial to Hematopoietic Transition

Primary Bone Marrow Stromal Cells Associated with Cytokines Induce ES-D3 Cells to Differentiate to Hematopoietic Cells in Vitro

[Effect of Different Hemopoietic Microenvironment on the Differentiation of Hemopoietic Cells from Human Embryonic Stem Cells].

Lineage Restriction and Differentiation of Human Embryonic Stem Cells into Hepatic Progenitors and Zone 1 Hepatocytes

Efficient Cardiomyocyte Differentiation of Embryonic Stem Cells by Bone Morphogenetic Protein-2 Combined with Visceral Endoderm-Like Cells.

Efficient and simultaneous generation of hematopoietic and vascular progenitors from human induced pluripotent stem cells

[Bone Marrow Endothelial Cell-Conditioned Medium Promotes Hematopoietic Differentiation of Mouse Embryonic Stem Cells].

Mapping the Pairwise Choices Leading from Pluripotency to Human Bone, Heart, and Other Mesoderm Cell Types

Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification.

Hypoxia Drives Hematopoiesis with the Enhancement of T Lineage Through Eliciting Arterial Specification of Hematopoietic Endothelial Progenitors from Hesc

Differentiation Of Embryonic Stem Cells To Vascular Cell Lineages

Co‐Differentiation of Human Pluripotent Stem Cells‐Derived Cardiomyocytes and Endothelial Cells from Cardiac Mesoderm Provides a Three‐Dimensional Model of Cardiac Microtissue